NYSE American accepts Picard Medical's compliance plan; listing continues through Nov 2027

Picard Medical, Inc.

NYSE American accepted compliance plan under Sections 1003(a)(i) and (ii) due to low equity and losses.
Company may continue listing on NYSE American under symbol PMI while executing the plan.
Compliance period through November 8, 2027, subject to quarterly review by NYSE American.
Company must achieve milestones set forth in the compliance plan to regain full compliance.
Interim CEO Richard Fang cites progress on Emperor Total Artificial Heart and financial position.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.